Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 4/2002

01-05-2002

Risk factors for medullary thyroid carcinoma: a pooled analysis

Authors: Eva Negri, Elaine Ron, Silvia Franceschi, Carlo La Vecchia, Susan Preston-Martin, Laurence Kolonel, Ruth A. Kleinerman, Kiyohiko Mabuchi, Fan Jin, Gun Wingren, Arne Hallquist, Fabio Levi, Athena Linos, Joseph F. Fraumeni Jr

Published in: Cancer Causes & Control | Issue 4/2002

Login to get access
Metadata
Title
Risk factors for medullary thyroid carcinoma: a pooled analysis
Authors
Eva Negri
Elaine Ron
Silvia Franceschi
Carlo La Vecchia
Susan Preston-Martin
Laurence Kolonel
Ruth A. Kleinerman
Kiyohiko Mabuchi
Fan Jin
Gun Wingren
Arne Hallquist
Fabio Levi
Athena Linos
Joseph F. Fraumeni Jr
Publication date
01-05-2002
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 4/2002
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1015263718760

Other articles of this Issue 4/2002

Cancer Causes & Control 4/2002 Go to the issue

OriginalPaper

Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women

OriginalPaper

Transient increase in breast cancer risk after giving birth: postpartum period with the highest risk (Sweden)

OriginalPaper

Meat consumption, cigarette smoking, and genetic susceptibility in the etiology of colorectal cancer: results from a Dutch prospective study

OriginalPaper

Breast self-examination: who teaches it, who is taught, and how often? (United States)

OriginalPaper

Cancer incidence in California flight attendants (United States)

OriginalPaper

Association of correlates of endogenous hormonal exposure with breast cancer risk in 426 families (United States)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits